EAACI Congress 2024
BackFT 19 - Flash talks on Hereditary Angioedema
Sunday 02 Jun, 15:00 PM -
16:30 PM Valencia, Spain
Palma
Flash Talks
15:00
Burden of Disease and Health-Related Quality of Life Impairment in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey
15:07
Analysis of prodromal symptoms and need for short-term prophylaxis in hereditary angioedema patients under long-term prophylaxis
15:14
Genital Attacks in Hereditary Angioedema And Their Effects On Sexual Life
15:21
Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data
15:28
Prospective monitoring of clinical outcomes and laboratory markers of hereditary angioedema in patients on long-term prophylaxis with lanadelumab: One-year follow-up
15:35
Under-representation and -reporting of race in global hereditary angioedema trials: A hidden yet alarming source of disparities
15:42
Long-term Real-Life Effectiveness and Tolerability of Lanadelumab in Hereditary Angioedema: The Bulgarian Experience
15:49
Comorbidities in hereditary angioedema patients in Canada: a quantitative survey study
15:56
Hereditary Angioedema (HAE) Patients Answer: Why Do Attacks Go Untreated?
16:03
Turkish National Hereditary Angioedema and Acquired Angioedema Registry, Established to Encourage Standardizing the Care and Management of the Disease. HAE/AAE-TR National Hereditary and Acquired Angioedema Registry Group
